SCHEMBL1679999

SCHEMBL1679999

CCc1nc2c(N3CCOCC3)nc(SCc3ccc(OC)c(N=O)c3)nc2n1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.43
HDAC1 Q13547 6/20 0.39
ALDH1A1 P00352 4/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE11A Q9HCR9 1/20 0.37
PIK3CD O00329 8/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PDE10A Q9Y233 1/20 0.36
PIK3CB P42338 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
HDAC3 O15379 2/20 0.35
HDAC4 P56524 2/20 0.35
HDAC7 Q8WUI4 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95758 0.89 PIK3CA (0.46) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL97744 0.88 PIK3CA (0.45) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL97915 0.87 ALDH1A1 (0.46) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL98503 0.87 PIK3CA (0.44) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL98098 0.87 PIK3CA (0.49) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL98394 0.87 ALDH1A1 (0.45) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL99312 0.86 PIK3CA (0.43) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL97922 0.86 PIK3CA (0.43) PIK3CAHDAC1ALDH1A1NPSR1PDE4A
SCHEMBL100480 0.85 ALDH1A1 (0.47) PIK3CAHDAC1ALDH1A1NPSR1LMNA
SCHEMBL99246 0.85 PIK3CA (0.43) PIK3CAHDAC1ALDH1A1NPSR1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088765-A1 PURINE DERIVATIVE AND ANTITUMOR AGENT USING SAME ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088765-A1 PURINE DERIVATIVE AND ANTITUMOR AGENT USING SAME PNP, TYMP, DPYD PIK3CA 1539/4885HDAC1 3179/4885ALDH1A1 336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.